|
|
|
University of Pittsburgh reports best gene delivery to date of protein missing in Duchenne Muscular Dystrophy
Using sophisticated techniques, University of Pittsburgh scientists have engineered perhaps the best gene therapy to date for the prevalent life-threatening disease, Duchenne muscular dystrophy. The research, conducted in animals and reported in the Nov. 28 issue of the Proceedings of the National Academy of Sciences, are remarkable on several fronts. Parent Project, NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases Contact:
Lauren Ward
wardle@msx.upmc.edu
412-624-2607
University of Pittsburgh Medical Center
Message posted by: Wouter Kalle
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|